Experts say, however, there’s no reason to panic.
Advocates have discovered that the drugmaker never sought exclusivity for manufacturing Truvada.
“If the plan does not explicitly address the unique needs of these populations, it will fail,” says Raniyah Copeland, president of the Black AIDS Institute.
The Viva Glam campaign is looking to its next 25 years.
And we spoke to activists who were there.
The bone marrow transplant that appears to have cleared the London patient’s HIV offers “a glimmer of hope,” activists tell Out, but the treatment is risky and unscalable.
The '80s drama is more relevant than ever.